Market Exclusive

Analyst Upgrades – Bristol-Myers Squibb (NYSE:BMY) Stock Gets Upgraded By Morgan Stanley from Equal Weight to Overweight

Analyst Ratings For Bristol-Myers Squibb (NYSE:BMY)

Today, Bristol-Myers Squibb (NYSE:BMY) stock received an upgrade by Morgan Stanley from Equal Weight to Overweight with a price target of $78.00.

Some recent analyst ratings include

Dividend information for Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 2.37% and an average dividend growth of 2.70% based on a 3 Year Average..

Dividend History for Bristol-Myers Squibb (NYSE:BMY)

Recent Insider Trading Activity For Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 69.56%.

Recent Trading Activity for Bristol-Myers Squibb (NYSE:BMY)
Shares of Bristol-Myers Squibb closed the previous trading session at 67.38 up +2.03 3.11% with 68.12999725341797 shares trading hands.

Exit mobile version